Skip to main navigation Skip to main content

CMH : Clinical and Molecular Hepatology

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Page Path

1
results for

"So Yeon Ryu"

Article category

Keywords

Publication year

"So Yeon Ryu"

Original Article

Viral hepatitis

Comparison and analysis of the prevalence of hepatitis C virus infection by region in the Republic of Korea during 2005-2012
Hae-Sook Shon, Hwa Young Choi, Jang Rak Kim, So Yeon Ryu, Youn-Jae Lee, Myeong Jin Lee, Hyun Ju Min, Jun Lee, Yeong Jun Song, Moran Ki
Clin Mol Hepatol 2015;21(3):249-256.
Published online September 30, 2015
DOI: https://doi.org/10.3350/cmh.2015.21.3.249
Background/Aims

This study compared the prevalence of hepatitis C virus (HCV) infection in the Republic of Korea and estimated the high-risk regions and towns.

Methods

National Health Insurance Service data for 8 years from 2005 to 2012 were used. The subjects of the study had visited medical facilities and been diagnosed with or received treatment for acute or chronic HCV as a primary or secondary disease according to ICD-10 codes of B17.1 or B18.2, respectively. Any patient who received treatment for the same disease multiple times during 1 year was counted as one patient in that year. To correct for the effect of the age structure of the population by year and region, the age-adjusted prevalence was calculated using the direct method based on the registered population in 2010.

Results

The overall prevalence of HCV infection among Korean adults (>20 years old) increased from 0.14% in 2005 to 0.18% in 2012. The sex-, age-, and region-adjusted prevalence in 2012 was 0.18%. The prevalence was highest in Busan, Jeonnam, and Gyeongnam, and there were towns with noticeably higher prevalences within these regions: Jindo (0.97%) in Jeonnam, Namhae (0.90%) in Gyeongnam, and Seo-gu (0.86%) in Busan.

Conclusions

The prevalence of HCV infection differs by regions as well as towns in the Republic of Korea, and is highest in Busan, Jeonnam, and Gyeongnam. The reasons for the high prevalence in these specific regions should be identified, since this could help prevent HCV infections in the future. In addition, active surveillance and treatment policies should be introduced to stop any further spread of infection in these high-prevalence regions.

Citations

Citations to this article as recorded by  Crossref logo
  • Economic evaluation of mass screening as a strategy for hepatitis C virus elimination in South Korea
    Hwa Young Choi, Kyung-Ah Kim, Bo Young Park, Bo Youl Choi, Moran Ki
    Journal of Infection and Public Health.2025; 18(3): 102662.     CrossRef
  • Insights into the spatial epidemiology of hepatitis C infection: systematic synthesis of area-level determinants and spatiotemporal analyses
    Jacob Mugoya Gizamba, Brian Karl Finch, Siqin Wang, Jeffrey D. Klausner
    BMC Public Health.2025;[Epub]     CrossRef
  • Temporal and geospatial patterns of hepatitis C virus prevalence: a longitudinal examination using national health insurance service data in the Republic of Korea (2005–2022)
    Hwa Young Choi, Moran Ki
    BMC Public Health.2025;[Epub]     CrossRef
  • Comorbidities and the use of comedications among patients with chronic hepatitis C in Korea: A nationwide cross-sectional study
    Kyung Min Kwon, Jae-Jun Shim, Gi-Ae Kim, Bo Ok Kim, Helin Han, Hyun Jung Ahn
    The Korean Journal of Internal Medicine.2023; 38(3): 338.     CrossRef
  • Clinical and histopathological analyses of kidney biopsies in a single center for 7 years
    Seunghye Lee, Sehyun Jung, Mi-Ji Kim, Jong Sil Lee, Ha Nee Jang, Se-Ho Chang, Hyun-Jung Kim
    Medicine.2022; 101(29): e29695.     CrossRef
  • The predictors of sustained virological response with sofosbuvir and ribavirin in patients with chronic hepatitis C genotype 2
    Sung Yong Han, Hyun Young Woo, Jeong Heo, Sang Gyu Park, Sung Ik Pyeon, Young Joo Park, Dong Uk Kim, Gwang Ha Kim, Hyung Hoi Kim, Geun Am Song, Mong Cho
    The Korean Journal of Internal Medicine.2021; 36(3): 544.     CrossRef
  • The changing epidemiology of liver diseases in the Asia–Pacific region
    Martin C. S. Wong, Jason L. W. Huang, Jacob George, Junjie Huang, Colette Leung, Mohammed Eslam, Henry L. Y. Chan, Siew C. Ng
    Nature Reviews Gastroenterology & Hepatology.2019; 16(1): 57.     CrossRef
  • Apolipoprotein E Genotype and Expression Correlated with Hepatitis C Virus Genotype and Infection
    Gyu-Nam Park, Hyun-Jung Jo, Hye-Ran Kim, Min-Ju Kim, Kyung-A Shin, Seung-Bok Hong, Kyung-Soo Chang
    Journal of Bacteriology and Virology.2019; 49(1): 27.     CrossRef
  • Incidence and Overall Survival of Biliary Tract Cancers in South Korea from 2006 to 2015: Using the National Health Information Database
    Byung-Woo Kim, Chang-Mo Oh, Hwa Young Choi, Joong-Won Park, Hyunsoon Cho, Moran Ki
    Gut and Liver.2019; 13(1): 104.     CrossRef
  • Why is Life Expectancy in Busan Shorter than in Seoul? Age and Cause-Specific Contributions to the Difference in Life Expectancy between Two Cities
    Young-Ho Khang, Jinwook Bahk
    Yonsei Medical Journal.2019; 60(7): 687.     CrossRef
  • Transmission routes of hepatitis C virus in Rahim Yar Khan: hospital based study
    M. Ali Malik, M.A. Rehman, Nadia Usman
    International Journal of Biosciences (IJB).2019; : 418.     CrossRef
  • Incidence and Prognosis of Subsequent Cholangiocarcinoma in Patients with Hepatic Resection for Bile Duct Stones
    Hyun Jung Kim, Tae Uk Kang, Heather Swan, Min Ji Kang, Nayoung Kim, Hyeong Sik Ahn, Seon Mee Park
    Digestive Diseases and Sciences.2018; 63(12): 3465.     CrossRef
  • Understanding the complications of anti‐tumor necrosis factor therapy in East Asian patients with inflammatory bowel disease
    Jae Hee Cheon
    Journal of Gastroenterology and Hepatology.2017; 32(4): 769.     CrossRef
  • Current status of hepatitis C virus infection and countermeasures in South Korea
    Sook-Hyang Jeong, Eun Sun Jang, Hwa Young Choi, Kyung-Ah Kim, Wankyo Chung, Moran Ki
    Epidemiology and Health.2017; 39: e2017017.     CrossRef
  • Efficacy and safety of sofosbuvir-based regimens for treatment in chronic hepatitis C genotype 1 patients with moderately impaired renal function
    Hyun Phil Shin, Ji-Ae Park, Blaire Burman, Richard A. Kozarek, Asma Siddique
    Clinical and Molecular Hepatology.2017; 23(4): 316.     CrossRef
  • Increased survival in hepatitis c patients who underwent living donor liver transplant: a case-control study with propensity score matching
    Jong Man Kim, Kwang-Woong Lee, Gi-Won Song, Bo-Hyun Jung, Hae Won Lee, Nam-Joon Yi, Choon Hyuck David Kwon, Shin Hwang, Kyung-Suk Suh, Jae-Won Joh, Suk-Koo Lee, Sung-Gyu Lee
    Annals of Surgical Treatment and Research.2017; 93(6): 293.     CrossRef
  • 12,261 View
  • 89 Download
  • 16 Web of Science
  • Crossref